134 related articles for article (PubMed ID: 32070696)
1. Lysyl Oxidase Like 1: Biological roles and regulation.
Greene AG; Eivers SB; Dervan EWJ; O'Brien CJ; Wallace DM
Exp Eye Res; 2020 Apr; 193():107975. PubMed ID: 32070696
[TBL] [Abstract][Full Text] [Related]
2. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
[TBL] [Abstract][Full Text] [Related]
3. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
[TBL] [Abstract][Full Text] [Related]
4. The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma.
Schlötzer-Schrehardt U; Zenkel M
Exp Eye Res; 2019 Dec; 189():107818. PubMed ID: 31563608
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-ß Levels and LOXL1 Genotype in Pseudoexfoliation.
Gayathri R; Coral K; Sharmila F; Sripriya S; Sripriya K; Manish P; Shantha B; Ronnie G; Vijaya L; Narayanasamy A
Curr Eye Res; 2016 Oct; 41(10):1331-1338. PubMed ID: 27116380
[TBL] [Abstract][Full Text] [Related]
6. Differential Lysyl oxidase like 1 expression in pseudoexfoliation glaucoma is orchestrated via DNA methylation.
Greene AG; Eivers SB; McDonnell F; Dervan EWJ; O'Brien CJ; Wallace DM
Exp Eye Res; 2020 Dec; 201():108349. PubMed ID: 33188817
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of lysyl oxidases LOXL1 and LOX during growth and aging suggests specific roles in elastin and collagen fiber remodeling in rat aorta.
Behmoaras J; Slove S; Seve S; Vranckx R; Sommer P; Jacob MP
Rejuvenation Res; 2008 Oct; 11(5):883-9. PubMed ID: 18803461
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
Zenkel M; Schlötzer-Schrehardt U
J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
[TBL] [Abstract][Full Text] [Related]
9. Genetics and genomics of pseudoexfoliation syndrome/glaucoma.
Schlötzer-Schrehardt U
Middle East Afr J Ophthalmol; 2011 Jan; 18(1):30-6. PubMed ID: 21572731
[TBL] [Abstract][Full Text] [Related]
10. [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].
Schlötzer-Schrehardt U
Ophthalmologe; 2012 Oct; 109(10):944-51. PubMed ID: 23053330
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Pseudoexfoliation Glaucoma Risk-associated Variants Within Lysyl Oxidase-like 1 in an Irish Population.
Eivers SB; Greene AG; Dervan E; O'Brien C; Wallace D
J Glaucoma; 2020 Jun; 29(6):417-422. PubMed ID: 32102031
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidase like-1 deficiency in optic nerve head astrocytes elicits reactive astrocytosis and alters functional effects of astrocyte derived exosomes.
Hariani HN; Ghosh AK; Rosen SM; Tso HY; Kessinger C; Zhang C; Jones WK; Sappington RM; Mitchell CH; Stubbs EB; Rao VR; Kaja S
Exp Eye Res; 2024 Mar; 240():109813. PubMed ID: 38331016
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
Schlötzer-Schrehardt U
Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
[TBL] [Abstract][Full Text] [Related]
14. Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome.
Zenkel M; Krysta A; Pasutto F; Juenemann A; Kruse FE; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8488-95. PubMed ID: 21948647
[TBL] [Abstract][Full Text] [Related]
15. Review: The role of LOXL1 in exfoliation syndrome/glaucoma.
Whigham BT; Allingham RR
Saudi J Ophthalmol; 2011 Oct; 25(4):347-52. PubMed ID: 23960948
[TBL] [Abstract][Full Text] [Related]
16. Lysyl oxidase-like 1 gene in the reversal of promoter risk allele in pseudoexfoliation syndrome.
Dubey SK; Hejtmancik JF; Krishnadas SR; Sharmila R; Haripriya A; Sundaresan P
JAMA Ophthalmol; 2014 Aug; 132(8):949-55. PubMed ID: 24809751
[TBL] [Abstract][Full Text] [Related]
17. Update on pseudoexfoliation syndrome pathogenesis and associations with intraocular pressure, glaucoma and systemic diseases.
Anastasopoulos E; Founti P; Topouzis F
Curr Opin Ophthalmol; 2015 Mar; 26(2):82-9. PubMed ID: 25594764
[TBL] [Abstract][Full Text] [Related]
18. Biological effect of LOXL1 coding variants associated with pseudoexfoliation syndrome.
Sharma S; Martin S; Sykes MJ; Dave A; Hewitt AW; Burdon KP; Ronci M; Voelcker NH; Craig JE
Exp Eye Res; 2016 May; 146():212-223. PubMed ID: 26997634
[TBL] [Abstract][Full Text] [Related]
19. Lysyl oxidase-like 1-antisense 1 (LOXL1-AS1) lncRNA differentially regulates gene and protein expression, signaling and morphology of human ocular cells.
Schmitt HM; Hake KM; Perkumas KM; Lê BM; Suarez MF; De Ieso ML; Rahman RS; Johnson WM; Gomez-Caraballo M; Ashley-Koch AE; Hauser MA; Stamer WD
Hum Mol Genet; 2023 Oct; 32(21):3053-3062. PubMed ID: 37540217
[TBL] [Abstract][Full Text] [Related]
20. Pseudoexfoliation syndrome and glaucoma: from genes to disease mechanisms.
Schlötzer-Schrehardt U; Khor CC
Curr Opin Ophthalmol; 2021 Mar; 32(2):118-128. PubMed ID: 33332884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]